MedTrace Logo

Functional Magnetic Resonance Imaging (fMRI) Exploration of Neurocognitive Processes Involved in Food Addiction (FA) in Obese Patients: Towards New Phenotypic Markers for an Optimized Care Pathway

NCT03454711 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2023-08-01

No results posted yet for this study

Summary

Identification of the cerebral fMRI phenotype of obese patients with FA in cognitive task context based on food choice making

Conditions

Interventions

DEVICE

fMRI

Brain MRI

DEVICE

Indirect calorimetry

Resting energy expenditure

DEVICE

Bioimpedance

Measurement of body composition

BIOLOGICAL

Lipid profile, glucose, HBA1c, metabolomic analysis

Blood sample

BEHAVIORAL

YFAS questionnaire, Binge Eating Scale, Hospital Anxiety and Depression (HAD) scale, hedonic evaluation test (liking)

Questionnaires to characterize eating habits and depression

Sponsors & Collaborators

  • Institut NuMeCan, INRAE 1341

    collaborator UNKNOWN

  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • David Val-Laillet, MSc, PhD, HDR · Institut NuMeCan, INRA 1341, INSERM 1241, Université de Rennes 1

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-26
Primary Completion
2021-09-08
Completion
2021-09-08

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03454711 on ClinicalTrials.gov